Table 3 Logistic regression analysis using DAS28-ESR and CDAI remission rates as objective variables
Factors | Odds ratio (95% CI) |
|---|---|
bDMARDs (compared with control group) | 2.38 (1.02–5.54) |
MTX (compared with control group) | 1.61 (0.86–3.02) |
Age | 1.00 (0.98–1.04) |
DAS28-ESR at baseline | 0.81 (0.60–1.11) |
Sex (male) | 2.12 (0.86–5.24) |
Steinbrocker stage | 0.55 (0.21–1.48) |
Disease duration | 1.02 (0.95–1.09) |
bDMARDs (compared with control group) | 3.24 (0.21–8.88) |
MTX (compared with control group) | 1.72 (0.87–3.37) |
Age | 0.99 (0.96–1.02) |
CDAI at baseline | 0.97 (0.93–1.02) |
Sex (male) | 0.87 (0.36–2.07) |
Steinbrocker stage | 0.31 (0.11–0.92) |
Disease duration | 1.01 (0.95–1.08) |